7-16421157-AC-ACC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001101426.4(CRPPA):c.165_166insG(p.Cys56ValfsTer60) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000424 in 1,179,224 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000042 ( 0 hom. )
Consequence
CRPPA
NM_001101426.4 frameshift
NM_001101426.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.925
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-16421157-A-AC is Pathogenic according to our data. Variant chr7-16421157-A-AC is described in ClinVar as [Pathogenic]. Clinvar id is 435529.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.165_166insG | p.Cys56ValfsTer60 | frameshift_variant | 1/10 | ENST00000407010.7 | NP_001094896.1 | |
LOC105375168 | XR_007060223.1 | n.297+181dup | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRPPA | ENST00000407010.7 | c.165_166insG | p.Cys56ValfsTer60 | frameshift_variant | 1/10 | 5 | NM_001101426.4 | ENSP00000385478 | P1 | |
CRPPA | ENST00000399310.3 | c.165_166insG | p.Cys56ValfsTer60 | frameshift_variant | 1/9 | 1 | ENSP00000382249 | |||
CRPPA | ENST00000674759.1 | c.-46-14821_-46-14820insG | intron_variant | ENSP00000502749 | ||||||
CRPPA | ENST00000675257.1 | c.-46-14821_-46-14820insG | intron_variant | ENSP00000501664 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000424 AC: 5AN: 1179224Hom.: 0 Cov.: 31 AF XY: 0.00000703 AC XY: 4AN XY: 569146
GnomAD4 exome
AF:
AC:
5
AN:
1179224
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
569146
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Muscular dystrophy-dystroglycanopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 11, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at